Neurocrine’s Next Big Step: Inside Its Strategic Buyout of Soleno
Neurocrine’s $2.9 Billion Bet: A Strategic Move Into Rare Diseases In a major move that could reshape its future, Neurocrine…
Tag: biotech acquisition
Gilead to Buy Arcellx in $7.8 Billion Cancer Therapy Deal
The biotech giant announced it will acquire its partner Arcellx in a deal worth up to $7.8 billion. The acquisition…